Skip to main content
. 2020 Jun 12;21:224. doi: 10.1186/s12882-020-01878-7

Table 1.

Baseline clinical characteristics in IMN patients with and without DM

Clinical characteristics Non-DM
(n = 164)
DM
(n = 42)
P-value
Age (years) 48 ± 15 60 ± 9 < 0.001
male (n, %) 94(57.3) 21 (50.0) 0.394
SBP (mmHg) 134 ± 20 137 ± 21 0.505
DBP (mmHg) 82 ± 12 78 ± 11 0.062
Hypertension (n, %) 71 (43.3) 17 (40.5) 0.742
Glomerular hematuria (n, %) 15 (9.1) 3 (7.1) 0.682
eGFR (ml/min/1.73m2) 91.5 ± 21.9 76.1 ± 27.1 0.001
Serum creatinine (μmol/L) 84 ± 45 96 ± 55 0.134
Proteinuria (g/24 h) 5.5 ± 3.8 7.2 ± 6.0 0.084
Albuminuria (g/24 h) 3.1 ± 2.1 3.4 ± 2.4 0.522
uPCR (mg/gCr) 4.4 ± 3.6 5.9 ± 4.9 0.074
uACR (mg/gCr) 2.4 ± 1.9 2.8 ± 2.2 0.173
Serum albumin (g/L) 22.4 ± 7.4 22.4 ± 5.7 0.943
Hemoglobin (g/L) 129.3 ± 20.2 120.3 ± 21.6 0.012
Blood uric acid (μmol/L) 427.2 ± 120.5 402.8 ± 103.8 0.232
Cholesterol (mmol/L) 8.7 ± 3.0 8.2 ± 2.5 0.349
Triglyceride (mmol/L) 3.1 ± 2.2 3.3 ± 2.1 0.588
HDL (mmol/L) 1.5 ± 0.5 1.5 ± 0.5 0.652
LDL (mmol/L) 5.5 ± 2.0 5.1 ± 1.7 0.233
Glycosylated hemoglobin (%) 5.6 ± 0.5 6.5 ± 1.0 < 0.001
Type of Diabetes (n, %)
Type 1 Diabetes 1 (2.4)
Type 2 Diabetes 31 (97.6)
Steroid diabetes 10 (23.8)
Duration of diabetes (n, %)
New-onset diabetes 27 (64.3)
Previous diabetes 15 (35.7)
Therapeutic regimen for DM (n, %)
Oral hypoglycemic drugs 27 (64.3)
Insulin 1 (2.4)
Lifestyle management 14 (33.3)

Data were expressed as mean ± SD (standard deviation), medians (interquartile range), or numbers (%)

DM diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, uPCR urine protein creatinine ratio, uACR urine albumin creatinine ratio, HDL high density lipoprotein, LDL low density lipoprotein